TNFRSF8 and anaplastic large cell lymphoma: The second most common group, representing approx. 25% of CTCL, is primary cutaneous CD30+ lymphoproliferative disorders (LPDs) including primary cutaneous anaplastic large lymphoma (C-ALCL) and lymphomatoid papulosis (LyP) [133].